| 2023-12-13 | +228.2% | news | Seeking Alpha | Shattuck Labs stock rallies 90% on Phase 1 data for blood cancer drug |
| 2023-12-13 | +228.2% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2024-10-01 | -63.3% | news | Seeking Alpha | Shattuck plunges after discontinuing lead candidate |
| 2024-10-01 | -63.3% | legal | SEC EDGAR | STTK 8-K: 1.02, 2.05, 8.01 (SEC Filing) |
| 2024-10-02 | -33.2% | news | Seeking Alpha | Shattuck cut to Neutral at Citi on program exit |
| 2021-11-09 | -33.1% | legal | SEC EDGAR | STTK 8-K: 2.02 and (SEC Filing) |
| 2025-09-02 | +30.7% | news | Investing.com | OrbiMed Advisors buys Shattuck Labs (STTK) shares worth $5.47 million - Investing.com |
| 2025-09-08 | +29.2% | analyst | Yahoo Finance | Shattuck Labs (STTK) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance |
| 2026-03-05 | +28.5% | news | GlobeNewswire | Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights |
| 2026-03-05 | +28.5% | earnings | Seeking Alpha | Shattuck Labs GAAP EPS of -$0.12 beats by $0.01 |
| 2026-03-05 | +28.5% | legal | SEC EDGAR | STTK 8-K: 2.02 and (SEC Filing) |
| 2026-03-05 | +28.5% | news | Stock Titan | Shattuck Labs tests new Crohn’s antibody, projects cash runway into 2029 - Stock Titan |
| 2026-03-05 | +28.5% | news | Stock Titan | Shattuck Labs (NASDAQ: STTK) cuts 2025 R&D spend, funds operations into 2029 - Stock Titan |
| 2024-06-14 | -28.1% | news | Seeking Alpha | Shattuck gains on early-stage data update for lead asset in blood cancer |
| 2025-08-14 | +23.5% | earnings | Seeking Alpha | Shattuck Labs GAAP EPS of -$0.24 in-line |
| 2025-08-14 | +23.5% | legal | SEC EDGAR | STTK 8-K: 2.02 (SEC Filing) |
| 2023-11-09 | -23.1% | earnings | Seeking Alpha | Shattuck Labs, Inc. 2023 Q3 - Results - Earnings Call Presentation |
| 2023-11-09 | -23.1% | earnings | Seeking Alpha | Shattuck Labs GAAP EPS of -$0.65 misses by $0.14, revenue of $0.69M beats by $0.52M |
| 2023-11-09 | -23.1% | legal | SEC EDGAR | STTK 8-K: 2.02 and (SEC Filing) |
| 2026-03-06 | +18.5% | news | Motley Fool | Why Shattuck Labs Stock Soared More Than 53% Higher This Week |
| 2026-03-06 | +18.5% | earnings | MT Newswires | Wedbush Raises Price Target on Shattuck Labs to $8 From $4, Keeps Outperform Rating |
| 2026-03-06 | +18.5% | news | The Motley Fool | Why Shattuck Labs Stock Soared More Than 53% Higher This Week - The Motley Fool |
| 2026-03-06 | +18.5% | analyst | NAI500 | Clinical Data Optimism Combined with Analyst Recommendation Drives Shattuck Labs Shares Up 53% This Week - NAI500 |
| 2026-03-06 | +18.5% | news | AD HOC NEWS | Shattuck Labs (STTK, US8124231002): What Recent Data Mean For Global Biotech Investors - AD HOC NEWS |
| 2024-08-02 | -14.1% | earnings | Seeking Alpha | Shattuck Labs GAAP EPS of -$0.42, revenue of $1.61M |
| 2022-07-29 | -11.2% | legal | SEC EDGAR | STTK 8-K: 1.01 and (SEC Filing) |
| 2022-11-08 | -10.7% | legal | SEC EDGAR | STTK 8-K: 2.02 and (SEC Filing) |
| 2023-08-10 | -10.7% | legal | SEC EDGAR | STTK 8-K: 2.02 and (SEC Filing) |
| 2025-10-08 | -10.5% | news | Yahoo Finance | What Makes Shattuck Labs, Inc. (STTK) a Strong Momentum Stock: Buy Now? - Yahoo Finance |
| 2025-08-05 | +10.0% | legal | SEC EDGAR | STTK 8-K: 1.01, 3.02, 7.01 (SEC Filing) |
| 2025-08-05 | +10.0% | news | The Business Journals | Biotech company lands $103M in new financing - The Business Journals |
| 2024-06-19 | -9.0% | news | Seeking Alpha | Hold For Now: Shattuck Labs' SL-172154 Potential In Early Trials |
| 2024-06-19 | -9.0% | news | Seeking Alpha | Hold For Now: Shattuck Labs' SL-172154 Potential In Early Trials (NASDAQ:STTK) - Seeking Alpha |
| 2026-02-06 | +8.8% | news | GlobeNewswire | Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium |
| 2026-02-06 | +8.8% | news | simplywall.st | Shattuck Labs Insider Buyers Net US$637k Despite 12% Stock Decline - simplywall.st |
| 2026-02-06 | +8.8% | news | Stock Titan | Inside Shattuck Labs' Piper Sandler immunology fireside chat - Stock Titan |
| 2025-03-27 | -8.3% | legal | SEC EDGAR | STTK 8-K: 2.02 (SEC Filing) |
| 2024-04-19 | -8.2% | analyst | eToro | Shattuck Labs In (STTK) Stock Price, News & Analyst Forecast - eToro |
| 2024-03-01 | +7.6% | earnings | Seeking Alpha | Shattuck Labs GAAP EPS of -$0.41 |
| 2026-01-22 | -7.1% | legal | SEC EDGAR | STTK 8-K: 1.01 and (SEC Filing) |
| 2026-01-22 | -7.1% | expansion | marketscreener.com | Shattuck Labs Inc enters $75 million common stock sales agreement with Leerink Partners - marketscreener.com |
| 2024-07-01 | -6.6% | news | Seeking Alpha | Shattuck Labs announces addition to Russell 2000 and Russell 3000 Indexes |
| 2024-02-29 | +6.0% | legal | SEC EDGAR | STTK 8-K: 2.02 (SEC Filing) |
| 2026-01-05 | +6.0% | news | The Motley Fool | Why Shattuck Labs Stock Soared in December - The Motley Fool |
| 2026-04-08 | +6.0% | news | Stock Titan | Shattuck Labs (NASDAQ: STTK) seeks approval of revamped equity plan at 2026 virtual meeting - Stock Titan |
| 2023-08-11 | -5.9% | earnings | Seeking Alpha | Shattuck Labs GAAP EPS of -$0.50, revenue of $0.2M |
| 2026-02-25 | -5.9% | news | GlobeNewswire | Shattuck Labs Announces Participation in Upcoming March Investor Conferences |
| 2022-03-15 | +5.8% | legal | SEC EDGAR | STTK 8-K: 2.02 and (SEC Filing) |
| 2023-02-23 | +5.4% | legal | SEC EDGAR | STTK 8-K: 2.02 and (SEC Filing) |
| 2025-11-07 | -5.2% | earnings | Seeking Alpha | Shattuck Labs GAAP EPS of -$0.14 |
| 2025-12-30 | +5.1% | news | simplywall.st | Shattuck Labs, Inc.'s (NASDAQ:STTK) biggest owners are retail investors who got richer after stock soared 10% last week - simplywall.st |
| 2024-08-01 | -5.0% | legal | SEC EDGAR | STTK 8-K: 2.02 (SEC Filing) |
| 2026-04-18 | +4.8% | news | Cổng thông tin điện tử Tỉnh Sơn La | Shattuck Labs (STTK) Stock Pending Order (Tick Up) 2026-04-18 - Community Momentum Stocks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2025-04-25 | -4.8% | news | Stock Titan | STTK Stock Price, News & Analysis - Stock Titan |
| 2025-12-15 | -4.7% | news | The Globe and Mail | Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail |
| 2024-02-14 | +4.7% | news | Seeking Alpha | Two biotech/pharma stocks to watch - STTK, KALV |
| 2024-06-10 | -4.5% | legal | Seeking Alpha | Shattuck gets FDA orphan drug designation for SL-172154 for AML |
| 2022-08-11 | -4.5% | legal | SEC EDGAR | STTK 8-K: 2.02 and (SEC Filing) |
| 2022-08-11 | -4.5% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Shattuck Labs (STTK) - Zacks Investment Research |
| 2025-05-26 | +4.4% | news | Intellectia AI | STTK Forecast — Price Prediction for 2026. Should I Buy STTK? - Intellectia AI |
| 2024-01-24 | +4.3% | news | Seeking Alpha | Shattuck Labs files to sell 3.1M shares for its holders |
| 2026-04-13 | -4.2% | news | Cổng thông tin điện tử tỉnh Tây Ninh | How expensive is Shattuck Labs (STTK) Stock now | Price at $6.97, Up 0.72% - Breakout Stocks - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-20 | +3.9% | earnings | MarketBeat | Shattuck Labs (NASDAQ:STTK) Stock Price Up 6% - What's Next? - MarketBeat |
| 2023-12-18 | -3.8% | news | Seeking Alpha | Shattuck Labs: Early Positive Data May Be A Harbinger Of Good Things |
| 2026-02-16 | +3.5% | news | AD HOC NEWS | Shattuck Labs Just Shocked Wall Street: Is STTK the Next Sleeper Biotech Rocket or Total Trap? - AD HOC NEWS |
| 2023-05-09 | +3.3% | legal | SEC EDGAR | STTK 8-K: 2.02 and (SEC Filing) |
| 2024-11-14 | +3.1% | earnings | Seeking Alpha | Shattuck Labs GAAP EPS of -$0.33 beats by $0.06, revenue of $3M |
| 2024-11-14 | +3.1% | legal | SEC EDGAR | STTK 8-K: 2.02 and (SEC Filing) |
| 2024-05-02 | -2.9% | earnings | Seeking Alpha | Shattuck Labs GAAP EPS of -$0.37, revenue of $1.11M |
| 2024-05-02 | -2.9% | legal | SEC EDGAR | STTK 8-K: 2.02 (SEC Filing) |
| 2026-02-05 | -2.7% | legal | SEC EDGAR | STTK 8-K: 8.01 (SEC Filing) |
| 2022-05-12 | +2.6% | legal | SEC EDGAR | STTK 8-K: 2.02 and (SEC Filing) |
| 2023-11-10 | +2.4% | earnings | Seeking Alpha | Shattuck Labs, Inc. (STTK) Q3 2023 Earnings Call Transcript |
| 2023-05-10 | -2.0% | earnings | Seeking Alpha | Shattuck Labs GAAP EPS of -$0.49 beats by $0.15, revenue of $0.06M misses by $0.03M |
| 2026-04-21 | -2.0% | earnings | MarketBeat | Shattuck Labs (NASDAQ:STTK) Hits New 1-Year High - Time to Buy? - MarketBeat |
| 2025-11-06 | -2.0% | legal | SEC EDGAR | STTK 8-K: 2.02 (SEC Filing) |
| 2024-06-11 | -2.0% | legal | SEC EDGAR | STTK 8-K: 5.02 (SEC Filing) |
| 2023-12-22 | +1.8% | legal | SEC EDGAR | STTK 8-K: 1.01, 3.02 (SEC Filing) |
| 2021-05-10 | -1.6% | legal | SEC EDGAR | STTK 8-K: 2.02 and (SEC Filing) |
| 2025-10-11 | -1.5% | news | Seeking Alpha | Shattuck Labs, Inc. (STTK) Presents At The United European Gastroenterology (UEG) Congress UEG Week 2025 Transcript |
| 2025-05-01 | -1.5% | earnings | Seeking Alpha | Shattuck Labs GAAP EPS of -$0.27 beats by $0.01 |
| 2025-05-01 | -1.5% | legal | SEC EDGAR | STTK 8-K: 2.02 and (SEC Filing) |
| 2026-01-28 | +1.5% | news | Seeking Alpha | Shattuck earns new Overweight at Piper Sandler ahead of upcoming catalysts |
| 2026-01-28 | +1.5% | news | Seeking Alpha | Shattuck earns new Overweight at Piper Sandler ahead of upcoming catalysts - Seeking Alpha |
| 2023-02-26 | +1.4% | earnings | Seeking Alpha | Shattuck Labs, Inc. (STTK) Q4 2022 Earnings Call Transcript |
| 2024-02-05 | +1.2% | news | TradingView | STTK Stock Price and Chart — NASDAQ:STTK - TradingView |
| 2023-12-21 | +1.2% | news | Seeking Alpha | Shattuck Labs: Positive Blood Cancer Data Leads To Mid-2024 Catalyst |
| 2023-12-21 | +1.2% | news | Seeking Alpha | Shattuck Labs announces $50M public offering of common stock and concurrent private placement of pre-funded warrants |
| 2023-12-21 | +1.2% | legal | SEC EDGAR | STTK 8-K: 8.01 (SEC Filing) |
| 2024-02-13 | +0.8% | legal | SEC EDGAR | STTK 8-K: 1.01 (SEC Filing) |
| 2026-01-16 | -0.8% | news | Seeking Alpha | Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot |
| 2026-01-16 | -0.8% | news | Seeking Alpha | Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot (STTK) - Seeking Alpha |
| 2024-05-11 | -0.7% | earnings | MarketBeat | Shattuck Labs (STTK) Stock Forecast and Price Target 2026 $STTK - MarketBeat |
| 2021-08-11 | +0.7% | legal | SEC EDGAR | STTK 8-K: 2.02 and (SEC Filing) |
| 2025-04-02 | +0.4% | earnings | Seeking Alpha | Shattuck Labs GAAP EPS of -$0.37 |
| 2021-10-28 | +0.4% | legal | SEC EDGAR | STTK 8-K: 5.02 and (SEC Filing) |
| 2024-03-04 | +0.2% | legal | SEC EDGAR | STTK 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-08-26 | -0.0% | legal | SEC EDGAR | STTK 8-K: 5.02, 7.01 (SEC Filing) |